Latest Insider Transactions at Teva Pharmaceutical Industries LTD (TEVA)
This section provides a real-time view of insider transactions for Teva Pharmaceutical Industries LTD (TEVA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TEVA PHARMACEUTICAL INDUSTRIES LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TEVA PHARMACEUTICAL INDUSTRIES LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2021
|
Brendan P. O'Grady EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,166
+6.78%
|
-
|
|
Mar 02
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
50,000
-43.84%
|
$500,000
$10.82 P/Share
|
|
Mar 02
2021
|
Brendan P. O'Grady EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
15,085
-50.36%
|
$150,850
$10.85 P/Share
|
|
Mar 01
2021
|
Richard Daniell Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct |
20,598
-65.68%
|
$205,980
$10.85 P/Share
|
|
Mar 01
2021
|
Sven Dethlefs EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
7,486
-9.75%
|
$74,860
$10.83 P/Share
|
|
Mar 01
2021
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
9,795
-16.58%
|
$97,950
$10.85 P/Share
|
|
Mar 01
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
10,912
-8.73%
|
$109,120
$10.83 P/Share
|
|
Mar 01
2021
|
Gianfranco Nazzi EVP, International Markets |
SELL
Open market or private sale
|
Direct |
75,587
-60.04%
|
$755,870
$10.87 P/Share
|
|
Mar 01
2021
|
Brendan P. O'Grady EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
73,127
-38.71%
|
$731,270
$10.88 P/Share
|
|
Mar 01
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
18,430
-86.11%
|
$184,300
$10.83 P/Share
|
|
Feb 28
2021
|
Richard Daniell Exec. VP, European Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
20,598
+39.64%
|
-
|
|
Feb 28
2021
|
Sven Dethlefs EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
17,346
+18.43%
|
-
|
|
Feb 28
2021
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
19,514
+24.83%
|
-
|
|
Feb 28
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
21,682
+14.78%
|
-
|
|
Feb 28
2021
|
Eliyahu Sharon Kalif EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,430
+50.0%
|
-
|
|
Feb 28
2021
|
Gianfranco Nazzi EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
15,177
+16.72%
|
-
|
|
Feb 28
2021
|
Brendan P. O'Grady EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
24,934
+19.48%
|
-
|
|
Feb 28
2021
|
Mark Sabag EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
20,598
+13.51%
|
-
|
|
Feb 28
2021
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,047
+7.51%
|
-
|
|
Feb 28
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,430
+46.27%
|
-
|
|
Feb 16
2021
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
2,079
-4.99%
|
$22,869
$11.13 P/Share
|
|
Feb 16
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
2,098
-1.99%
|
$23,078
$11.12 P/Share
|
|
Feb 16
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,926
-56.9%
|
$43,186
$11.12 P/Share
|
|
Feb 14
2021
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,926
+8.61%
|
-
|
|
Feb 14
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,355
+4.84%
|
-
|
|
Feb 14
2021
|
Mark Sabag EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
5,712
+4.88%
|
-
|
|
Feb 14
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,926
+36.26%
|
-
|
|
Feb 09
2021
|
Richard Daniell Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct |
68,422
-50.14%
|
$821,064
$12.72 P/Share
|
|
Feb 09
2021
|
Richard Daniell Exec. VP, European Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
55,287
+41.11%
|
-
|
|
Feb 09
2021
|
Richard Daniell Exec. VP, European Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
13,135
+35.47%
|
-
|
|
Feb 09
2021
|
Sven Dethlefs EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
29,657
-17.57%
|
$355,884
$12.69 P/Share
|
|
Feb 09
2021
|
Sven Dethlefs EVP, North America Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
55,287
+38.3%
|
-
|
|
Feb 09
2021
|
Sven Dethlefs EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
13,135
+28.0%
|
-
|
|
Feb 09
2021
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
17,979
-17.0%
|
$215,748
$12.72 P/Share
|
|
Feb 09
2021
|
Eric Drape Executive VP Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
27,643
+33.17%
|
-
|
|
Feb 09
2021
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
6,567
+18.96%
|
-
|
|
Feb 09
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
29,496
-11.82%
|
$353,952
$12.69 P/Share
|
|
Feb 09
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Grant, award, or other acquisition
|
Direct |
67,852
+34.38%
|
-
|
|
Feb 09
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
16,120
+20.72%
|
-
|
|
Feb 09
2021
|
Gianfranco Nazzi EVP, International Markets |
SELL
Open market or private sale
|
Direct |
21,635
-13.75%
|
$259,620
$12.72 P/Share
|
|
Feb 09
2021
|
Gianfranco Nazzi EVP, International Markets |
BUY
Grant, award, or other acquisition
|
Direct |
50,260
+37.99%
|
-
|
|
Feb 09
2021
|
Gianfranco Nazzi EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
11,941
+27.31%
|
-
|
|
Feb 09
2021
|
Brendan P. O'Grady EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
20,694
-10.82%
|
$248,328
$12.69 P/Share
|
|
Feb 09
2021
|
Brendan P. O'Grady EVP, North America Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
67,852
+40.71%
|
-
|
|
Feb 09
2021
|
Brendan P. O'Grady EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
16,120
+34.22%
|
-
|
|
Feb 09
2021
|
Mark Sabag EVP, International Markets |
BUY
Grant, award, or other acquisition
|
Direct |
65,339
+38.22%
|
-
|
|
Feb 09
2021
|
Mark Sabag EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
15,523
+27.82%
|
-
|
|
Feb 09
2021
|
Kare Schultz President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
226,173
+23.51%
|
-
|
|
Feb 09
2021
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,867
+5.01%
|
-
|
|
Feb 09
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
65,312
-56.51%
|
$783,744
$12.69 P/Share
|